Chief Executive Officer of Biomarin Pharmaceutical Inc (NASDAQ:BMRN), Bienaime Jean Jacques, sells 1,500 shares worth $133,155
According to Biomarin Pharmaceutical Inc's most recent Statement Of Changes In Beneficial Ownership - Form 4 filing with the SEC dated Dec 30 08:02 PM, company Chief Executive Officer, Bienaime Jean Jacques disclosed selling 1,500 shares at a cost of $88.77. At the time of this transaction (Dec 28), this trade was worth $133,155 in total. As of Dec 28, Bienaime Jean Jacques now owns 297,052 shares in total worth about $25,831,641.919999998.
For the last few recent trades made by Biomarin Pharmaceutical Inc (NASDAQ:BMRN) Chief Executive Officer, Bienaime Jean Jacques, we have the following information:
- SEC Form 4 filing: May 08: Sold 20,000 shares at the rate of $91.72 per share. Total worth of this trade was $1,834,400. Total number of shares owned as of May 08 were 298,552
- SEC Form 4 filing: May 01: Sold 4,000 shares at the rate of $89.38 per share. Total worth of this trade was $357,520. Total number of shares owned as of May 01 were 298,552
- SEC Form 4 filing: May 04: Sold 5,000 shares at the rate of $88.00 per share. Total worth of this trade was $440,000. Total number of shares owned as of May 04 were 298,552
Posted by
George Daniels
on Wednesday December 30 2020, 10:13 PM EDT.
All trademarks acknowledged.
Filed under Business, Stocks.
Comments and Trackbacks closed.
Follow responses:
RSS 2.0
